arsenic trioxide has been researched along with dinoprostone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bazarbachi, A; de Thé, H; Habib, A; Hamade, E; Mahfouz, R; Nasrallah, MS | 1 |
| Binet, F; Chiasson, S; Girard, D | 1 |
| Huang, D; Liu, Y; Qi, Y; Zhang, W; Zhang, X; Zhang, Y | 1 |
3 other study(ies) available for arsenic trioxide and dinoprostone
| Article | Year |
|---|---|
Arsenic trioxide inhibits ATRA-induced prostaglandin E2 and cyclooxygenase-1 in NB4 cells, a model of acute promyelocytic leukemia.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; CD11c Antigen; Cell Differentiation; Cyclooxygenase 1; Dinoprostone; Drug Therapy, Combination; Humans; Indomethacin; Leukemia, Promyelocytic, Acute; Models, Biological; Oxides; Tretinoin; Tumor Cells, Cultured | 2008 |
Interaction between arsenic trioxide (ATO) and human neutrophils.
Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Cells, Cultured; Cytokines; Dinoprostone; Endoplasmic Reticulum; Enzyme-Linked Immunosorbent Assay; Humans; Neutrophils; NF-kappa B; Oxides; Protein Array Analysis; Transcription Factor CHOP | 2011 |
Arsenic trioxide inhibits invasion/migration in SGC-7901 cells by activating the reactive oxygen species-dependent cyclooxygenase-2/matrix metalloproteinase-2 pathway.
Topics: Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Movement; Cyclooxygenase 2; Dinoprostone; Enzyme Activation; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Intracellular Space; Leukotriene B4; Matrix Metalloproteinase 2; Neoplasm Invasiveness; Oxides; Reactive Oxygen Species; Signal Transduction; Thromboxane B2 | 2011 |